Literature DB >> 24160275

Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.

Adam R Schmitt1, Jeremy S Bordeaux.   

Abstract

Actinic keratosis is a common dermatologic condition that may regress, remain stable, or progress to squamous cell carcinoma. Some question whether all actinic keratoses should be routinely treated, whereas others contend that the unpredictable natural history of this disease necessitates treatment to prevent malignant transformation. Available treatments include photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, and diclofenac. Each of these options has its advantages and disadvantages, although they all have a place in the management of actinic keratosis. An overview of these treatment modalities is presented, as are the controversies surrounding the treatment of actinic keratosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24160275     DOI: 10.1016/j.clindermatol.2013.05.007

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  5 in total

1.  How Wounding via Lasers Has Potential Photocarcinogenic Preventative Effects via Dermal Remodeling.

Authors:  Aleksandar Krbanjevic; Jeffrey B Travers; Dan F Spandau
Journal:  Curr Dermatol Rep       Date:  2016-07-07

Review 2.  Multifocal epithelial tumors and field cancerization: stroma as a primary determinant.

Authors:  G Paolo Dotto
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

3.  Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study.

Authors:  Daisy Kopera; Helmut Kerl
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

Review 4.  Wounding Therapies for Prevention of Photocarcinogenesis.

Authors:  Timothy C Frommeyer; Craig A Rohan; Dan F Spandau; Michael G Kemp; Molly A Wanner; Elizabeth Tanzi; Jeffrey B Travers
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

5.  Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports-Perspective for non melanoma skin cancer prevention.

Authors:  Daisy Kopera
Journal:  Dermatol Ther       Date:  2020-06-30       Impact factor: 2.851

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.